Skip to main content
Log in

Use of flumazenil in intoxicated patients with coma

A double-blind placebo-controlled study in ICU

  • Originals
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil. In 23 patients admitted to the Intensive Care Unit with coma due to overdose with benzodiazepines or other sedatives, flumazenil i.v. (up to 2mg or placebo) was given. In 13 patients given flumazenil the Glasgow Coma Scale (GCS) increased significantly from 4.9 to 7.8 (p<0.05). Six of these 13 patients, including mainly benzodiazepine mono-intoxications, needed only one series of injections (up to 1.0 mg flumazenil); the GCS increased thereby from 4.5 to 10.7 within a maximum of 5 min (p<0.01). In the remaining 7 patients, needing two series of injections of flumazenil (up to 2.0 mg), GCS did not rise significantly and coma was related to intoxications with nonbenzodiazepine sedatives, flunitrazepam and in one patient, encephalitis. In the 10 patients receiving placebo, the GCS did not change. A significant increase in the GCS from 5.5 to 10.8 (p<0.001) was, however, observed when flumazenil (up to 1.0 mg) was given after placebo. In patients with EEG monitoring the changes in waveform pattern paralleled the clinical response. Effects could be detected within 1–2min after flumazenil injection and lasted up to 45min. There were no adverse reactions or benzodiazepine withdrawal symptoms. We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose. The use of flumazenil is of diagnostic value in mixed-drug intoxications or coma of unknown origin and is of therapeutic importance for reversal of benzodiazepine intoxications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Müller RKM, Haefely W (1982) Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects. Psychopharmacology 78:8–18

    Google Scholar 

  2. Lauven PM, Stoeckel H, Schwilden H, Arendt R, Greenblatt DJ, Schüttler J (1982) Application of a benzodiazepine antagonist (Ro 15-1788) under steady-state conditions of midazolam. Anesthesiology 57:A325

    Google Scholar 

  3. Polc P, Bonetti EP, Schaffner R, Haefely W (1982) A threestate model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, ß-carbolines, and phenobarbitone. Naunyn Schmiedebergs Arch Pharmacol 321:260–264

    Google Scholar 

  4. Louis M, Forster A, Suter PM, Gemperle M (1984) Clinical and hemodynamic effects of a specific benzodiazepine antagonist (Ro 15-1788) after open heart surgery. Anaesthesiology 61 [Suppl]:A61

    Google Scholar 

  5. Alon E, Baitella L, Hossli G (1985) Ro 15-1788 in reversing midazolam used for laparoscopy (preliminary communications). Acta Anaesthesiol Scand [Suppl]:80, 89

    Google Scholar 

  6. Geller E, Niv D, Matzkin C, Silbiger A, Nevo I, Cohen F, Braf Z (1985) The antagonism of midazolam sedation by Ro 15-1788 in postoperative patients. Anesthesiology 63 [Suppl]:A369

    Google Scholar 

  7. Roncari G, Ziegler WH, Guentert TW (1986) Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration. Br J Clin Pharmacol 22:421–428

    Google Scholar 

  8. Ziegler WH, Schalch E (1983) Antagonism of benzodiazepine-induced sedation in man. In: Koella W (ed) 6th Europ congress in sleep research, Zürich. Karger, Basel, 1983, pp 427–429

    Google Scholar 

  9. Forster A, Rouiller M, Morel D, Gemperle M (1983) Doubleblind randomized study evaluating a specific benzodiazepine antagonist. Anesthesiology 59:A375

    Google Scholar 

  10. Klotz U, Ziegler G, Reimann IW (1984) Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol 27:115–117

    Google Scholar 

  11. Hofer P, Scollo-Lavizzari G (1985) Benzodiazepine antagonist Ro 15-1788 in self poisoning. Diagnostic and therapeutic use. Arch Intern Med 145:663–664

    Google Scholar 

  12. Lheureux P, Askenasi R (1986) Benzodiazepine antagonist Ro 15-1788 in self-poisoning. Arch Intern Med 146:1241

    Google Scholar 

  13. Geller E, Niv D, Silbiger A, Halpern P, Leykin Y, Rudick V, Sorkin P (1986) Ro 15-1788, a benzodiazepine antagonist in the treatment of 34 intoxicated patients. Anesthesiology 63 [Suppl]:A157

    Google Scholar 

  14. Geller E, Niv D, Rudick V, Vidne B (1984) The use of Ro 15-1788: A benzodiazepine antagonist Ro the diagnosis and treatment of benzodiazepine overdose. Anesthesiology 61 [Suppl]:A135

    Google Scholar 

  15. Kleiberger G, Grimm G, Laggner A, Druml W, Lenz K, Schneeweiss B (1985) Weaning patients from mechanical ventilation by benzodiazepine antagonist Ro 15-1788. Lancet II:268–269

    Google Scholar 

  16. Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet II:81–83

    Google Scholar 

  17. Silverman D (1963) Retrospective study of the EEG in coma. Electroenceph Clin Neurophysiol 15:486–503

    Google Scholar 

  18. Greenblatt DJ, Shader R, Abernethy DR (1983) Drug therapy. Current status of benzodiazepines (second of two parts). N Engl J Med 309:410–416

    Google Scholar 

  19. Meier PJ, Ziegler WH, Neftel K (1988) Benzodiazepine-Praxis und Probleme über Anwendung. Schweiz Med Wochenschr 118:381–392

    Google Scholar 

  20. Baird ES, Hailey DM (1972) Delayed recovery from a sedative; correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. Br J Anaesth 44:803

    Google Scholar 

  21. Rapolt HJ, Follath F, Scollo-Lavizzari G, Kehl O, Ritz R (1984) Verlängertes Koma durch Sedation mit Diazepam bei beatmeten Patienten. Dtsch Med Wochenschr 109:340–344

    Google Scholar 

  22. Teasdale G, Murray G, Parker L, Jennett B (1979) Adding up the Glasgow Coma Score. Acta Neurochir [Suppl] 28:13–16

    Google Scholar 

  23. Geller E, Niv D, Silbinger A, Halpern P, Leykin Y, Rudick V, Sorkin P (1985) Ro 15-1788: a benzodiazepine antagonist in the treatment of 34 intoxicated patients. Anesthesiology 63:A157

    Google Scholar 

  24. Zuber M, Elsasser S, Ritz R, Scollo-Lavizzari G (1988) Flumazenil (Anexate®) in severe intoxication with carbamazepine (Tegretol®). Eur Neurol 28:161–163

    Google Scholar 

  25. Hruby K, Prischl F, Donner A, Grimm G, Smetana R (1988) Value of flumazenil in benzodiazepine self-poisoning. Eur Anaesthesiol [Suppl] 2:309–313

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritz, R., Zuber, M., Elsasser, S. et al. Use of flumazenil in intoxicated patients with coma. Intensive Care Med 16, 242–247 (1990). https://doi.org/10.1007/BF01705159

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01705159

Key words

Navigation